Liver Diseases  >>  cyclosporine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00644761: PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

Completed
2
16
US
Adefovir Dipivoxil
Gilead Sciences
Hepatitis B
05/05
05/05
TILT, NCT00105235: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

Completed
2
27
US, Canada
Alemtuzumab, Campath, Cyclosporine, Mycophenolate mofetil, CellCept, Tacrolimus, FK-506, Fujimycin, Liver transplant, Immunosuppression withdrawal
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)
Liver Disease, Liver Transplantation
03/07
03/11
NCT01938625 / 2013-002726-23: A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Checkmark ILC 2015
Apr 2015 - Apr 2015: ILC 2015
Completed
2
35
Europe
Simeprevir, Daclatasvir, Ribavirin, Cyclosporine, Tacrolimus
Janssen R&D Ireland
Hepatitis C, Chronic
04/15
07/15
NCT01374750: Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)

Completed
2
45
RoW
Sirolimus, Rapamune, m-TOR inhibitor free, Tacrolimus, Cyclosporine
Seoul National University Hospital
Hepatocellular Carcinoma
05/16
05/16

Download Options